top of page

VNDA

Vanda Pharmaceuticals Inc.

Price

chg

chg neg

quotes and stock data may be delayed 15 minutes

 My Notes

Only BPIQ Pro members can create company notes. Learn more here.

52 wk low

low api

52 wk hi

high api

Cash

$454.8M

Burn Rate (Qtr)

N/A

Mkt Cap

mkt cap api

Avg Volume

volume api

*cash/burn updated:

Q3 '22

Drug Pipeline

Click the button to see the updated pipeline

No drug found

We don't have any drug data for this company yet

Drug | Disease (links)

Stage (next event)

Catalyst Date

Drug Name

Indication

Phase

Event

Exp Date

A free account is required to see the catalyst dates, notes, and more!

Create Free Account Now

Loading Catalysts...

search in progress

Pipeline powered by

VNDA

BPIQ_Logo_RGB-01.jpg

Company Profile

Vanda is a specialty pharmaceutical company focused on the development and commercialization of novel therapies to address high unmet medical needs and improve the lives of patients.

Recent Posts

See what the community is saying - click to see full post.

Upcoming September 2020 COVID-19 Therapeutic Catalyst Event

VNDA - Interim Analysis from #ODYSSEY Study Shows Tradipitant may Accelerate Clinical Improvement in Patients with COVID_19 Pneumonia

VNDA - Tradipitant - Atopic Dermatitis - Phase 3

VNDA

bottom of page